Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CORT

Corcept Therapeutics Inc

May 22 • 04:00PM ET

60.22

+0.53 0.89 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: VKTX MDGL KRYS EXEL PTCT

| Held by: IJR VTI FBT VB VBK SPSM IJT VXF IWP SLYG

Scroll to Statements

Index	-	P/E	172.06	EPS (ttm)	0.35	Insider Own	12.66%	Shs Outstand	107.33M	Perf Week	6.83%
Market Cap	6.46B	Forward P/E	31.33	EPS next Y	1.92	Insider Trans	-1.13%	Shs Float	93.76M	Perf Month	33.58%
Enterprise Value	6.14B	PEG	0.47	EPS next Q	0.01	Inst Own	73.90%	Short Float	11.42%	Perf Quarter	70.40%
Income	46.67M	P/S	8.41	EPS this Y	-29.88%	Inst Trans	4.14%	Short Ratio	7.18	Perf Half Y	-20.87%
Sales	769.10M	P/B	10.13	EPS next Y	234.23%	ROA	5.62%	Short Interest	10.71M	Perf YTD	73.05%
Book/sh	5.94	P/C	19.12	EPS next 5Y	66.81%	ROE	7.06%	52W High	91.00 -33.82%	Perf Year	-20.86%
Cash/sh	3.15	P/FCF	53.97	EPS past 3/5Y	-2.15% -0.84%	ROIC	7.22%	52W Low	28.66 110.12%	Perf 3Y	144.40%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	23.74% 16.56%	Gross Margin	98.25%	Volatility	4.16% 4.34%	Perf 5Y	179.83%
Dividend TTM	-	EV/Sales	7.98	EPS Y/Y TTM	-64.76%	Oper. Margin	-1.07%	ATR (14)	2.37	Perf 10Y	1025.61%
Dividend Ex-Date	-	Quick Ratio	2.74	Sales Y/Y TTM	12.20%	Profit Margin	6.07%	RSI (14)	74.53	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	2.83	EPS Q/Q	-276.49%	SMA20	13.39%	Beta	0.41	Target Price	86.25
Payout	0.00%	Debt/Eq	0.02	Sales Q/Q	4.89%	SMA50	32.78%	Rel Volume	0.36	Prev Close	59.69
Employees	730	LT Debt/Eq	0.01	Earnings	Apr 30 AMC	SMA200	1.04%	Avg Volume	1.49M	Price	60.22
IPO	Apr 14, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	-172.23% -10.99%	Trades		Volume	536,139	Change	0.89%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)